drugset / Trial / NCT00680940

A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer

NCT00680940 ↗

Phase 2 Completed 221 enrolled Cadila Pharnmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Mycobacterium w in combination with Paclitaxel plus Cisplatin are effective in Advanced Non Small Cell Lung cancer.

Timeline

Start
2008-06
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified — —
Subject Mycobacterium w Vaccine — —
Comparator Paclitaxel Small molecule — —